id	sid	eid	entity	type
admet-1427	1	1	289	CARDINAL
admet-1427	1	2	2022	CARDINAL
admet-1427	1	3	289	CARDINAL
admet-1427	1	4	issn	PERSON
admet-1427	1	5	1848-7718	DATE
admet-1427	1	6	nanami nakatani	PERSON
admet-1427	1	7	kiyohiko sugano	PERSON
admet-1427	1	8	1	CARDINAL
admet-1427	1	9	noji-higashi	PERSON
admet-1427	1	10	kusatsu	PERSON
admet-1427	1	11	525-8577	CARDINAL
admet-1427	1	12	japan	GPE
admet-1427	2	1	561	CARDINAL
admet-1427	2	2	june 27	DATE
admet-1427	2	3	2022	CARDINAL
admet-1427	2	4	september 02	DATE
admet-1427	2	5	2022	CARDINAL
admet-1427	2	6	september 07	DATE
admet-1427	2	7	2022	CARDINAL
admet-1427	3	1	eleven	CARDINAL
admet-1427	3	2	seven	CARDINAL
admet-1427	4	1	10 %	PERCENT
admet-1427	6	1	5	CARDINAL
admet-1427	6	2	sec	ORG
admet-1427	10	1	2022	CARDINAL
admet-1427	14	1	1,2	CARDINAL
admet-1427	15	1	3	CARDINAL
admet-1427	15	2	4	CARDINAL
admet-1427	19	1	2	CARDINAL
admet-1427	21	1	5	CARDINAL
admet-1427	23	1	more than a dozen	CARDINAL
admet-1427	23	2	1	CARDINAL
admet-1427	23	3	konstantin tsinman	PERSON
admet-1427	23	4	nakatani	PERSON
admet-1427	23	5	2022	CARDINAL
admet-1427	23	6	289	CARDINAL
admet-1427	25	1	6–9	CARDINAL
admet-1427	26	1	10,11	CARDINAL
admet-1427	29	1	eleven	CARDINAL
admet-1427	29	2	seven	CARDINAL
admet-1427	29	3	1	CARDINAL
admet-1427	29	4	1	CARDINAL
admet-1427	34	1	ofloxacin	PERSON
admet-1427	34	2	ch3 n o n	ORG
admet-1427	36	1	ch3 n o n n nh	ORG
admet-1427	38	1	ch3 n n f n	PERSON
admet-1427	40	1	ch3 n	ORG
admet-1427	40	2	ch3 n	PERSON
admet-1427	44	1	ch3 n	ORG
admet-1427	46	1	ch3 n nh ch3 f	ORG
admet-1427	54	1	1	CARDINAL
admet-1427	55	1	nflx	ORG
admet-1427	55	2	ofloxacin	PERSON
admet-1427	55	3	1-octanol	QUANTITY
admet-1427	55	4	sodium dihydrogen phosphate dihydrate	ORG
admet-1427	55	5	decane	PERSON
admet-1427	55	6	8	CARDINAL
admet-1427	55	7	0.1	CARDINAL
admet-1427	55	8	vol%	ORG
admet-1427	55	9	2022	CARDINAL
admet-1427	55	10	289	CARDINAL
admet-1427	55	11	291	CARDINAL
admet-1427	55	12	osaka	GPE
admet-1427	55	13	japan	GPE
admet-1427	56	1	tci (tokyo	ORG
admet-1427	56	2	japan	GPE
admet-1427	57	1	gatifloxacin	PERSON
admet-1427	57	2	funakoshi co., ltd (	ORG
admet-1427	57	3	tokyo	GPE
admet-1427	57	4	japan	GPE
admet-1427	58	1	moxifloxacin	PERSON
admet-1427	58	2	combiblocks inc.	ORG
admet-1427	58	3	san diego	GPE
admet-1427	59	1	2-morpholinoethanesulfonic	MONEY
admet-1427	59	2	tokyo	GPE
admet-1427	59	3	japan	GPE
admet-1427	60	1	0.1	CARDINAL
admet-1427	60	2	vol%	ORG
admet-1427	60	3	kanto chemical co.	ORG
admet-1427	60	4	inc (tokyo	ORG
admet-1427	60	5	japan	GPE
admet-1427	61	1	tsuji oil mills co., ltd (mie	ORG
admet-1427	61	2	japan	GPE
admet-1427	61	3	24-32 %	PERCENT
admet-1427	61	4	20-28 %	PERCENT
admet-1427	61	5	12-20 %	PERCENT
admet-1427	61	6	8-15 %	PERCENT
admet-1427	61	7	1-5 %	PERCENT
admet-1427	62	1	1	CARDINAL
admet-1427	63	1	331 6.1	CARDINAL
admet-1427	63	2	8.7	CARDINAL
admet-1427	63	3	± 0.15 335	MONEY
admet-1427	64	1	12	CARDINAL
admet-1427	64	2	320 6.3	CARDINAL
admet-1427	64	3	8.7 -1.20 ± 0.39 330	QUANTITY
admet-1427	65	1	12	CARDINAL
admet-1427	65	2	369 5.5	DATE
admet-1427	65	3	8.1	CARDINAL
admet-1427	65	4	± 0.10 283	CARDINAL
admet-1427	65	5	12	CARDINAL
admet-1427	65	6	375 5.7	CARDINAL
admet-1427	65	7	8.7	CARDINAL
admet-1427	65	8	13	CARDINAL
admet-1427	65	9	361 6.1	CARDINAL
admet-1427	65	10	8.2	CARDINAL
admet-1427	65	11	± 0.11 335	CARDINAL
admet-1427	66	1	14	CARDINAL
admet-1427	66	2	401 6.4	CARDINAL
admet-1427	66	3	9.5	CARDINAL
admet-1427	67	1	12	CARDINAL
admet-1427	67	2	nflx	ORG
admet-1427	67	3	319 6.3	DATE
admet-1427	67	4	8.4	CARDINAL
admet-1427	68	1	12	CARDINAL
admet-1427	68	2	361 6.1	CARDINAL
admet-1427	68	3	8.2	CARDINAL
admet-1427	68	4	± 0.12 330	CARDINAL
admet-1427	68	5	12	CARDINAL
admet-1427	68	6	461 5.6	CARDINAL
admet-1427	68	7	6.3 0.86 ± 0.02 283	QUANTITY
admet-1427	69	1	15	CARDINAL
admet-1427	69	2	392 6.3	CARDINAL
admet-1427	69	3	8.8	CARDINAL
admet-1427	70	1	12	CARDINAL
admet-1427	70	2	404	CARDINAL
admet-1427	70	3	8.7 -0.14 ± 0.10 270	MONEY
admet-1427	71	1	16	CARDINAL
admet-1427	72	1	±	CARDINAL
admet-1427	72	2	3	CARDINAL
admet-1427	72	3	the pampa sandwich	ORG
admet-1427	72	4	96	CARDINAL
admet-1427	72	5	0.45 μm	MONEY
admet-1427	72	6	merck millipore	PERSON
admet-1427	72	7	ma, usa	ORG
admet-1427	73	1	300	CARDINAL
admet-1427	73	2	50 mm	QUANTITY
admet-1427	73	3	6.5	CARDINAL
admet-1427	74	1	5	CARDINAL
admet-1427	74	2	10 %	PERCENT
admet-1427	74	3	11	CARDINAL
admet-1427	76	1	17	CARDINAL
admet-1427	77	1	0.5 mm	QUANTITY
admet-1427	77	2	6.5 50 mm	QUANTITY
admet-1427	77	3	200	CARDINAL
admet-1427	78	1	37 °	QUANTITY
admet-1427	78	2	3	CARDINAL
admet-1427	79	1	150	CARDINAL
admet-1427	80	1	1	CARDINAL
admet-1427	81	1	kyoto	GPE
admet-1427	81	2	japan	GPE
admet-1427	81	3	zorbax	LOC
admet-1427	81	4	3.5	CARDINAL
admet-1427	81	5	0.60 ml	QUANTITY
admet-1427	81	6	20 %	PERCENT
admet-1427	81	7	0.1	CARDINAL
admet-1427	81	8	vol%	ORG
admet-1427	81	9	80 %	PERCENT
admet-1427	81	10	0.1	CARDINAL
admet-1427	81	11	vol%	ORG
admet-1427	81	12	270	CARDINAL
admet-1427	81	13	40 °	CARDINAL
admet-1427	81	14	10	CARDINAL
admet-1427	83	1	17	CARDINAL
admet-1427	84	1	2022	CARDINAL
admet-1427	84	2	289	CARDINAL
admet-1427	86	1	2.303𝑉d	CARDINAL
admet-1427	86	2	1 1+𝑟𝑣	CARDINAL
admet-1427	86	3	1+𝑟v 1−𝑅	DATE
admet-1427	87	1	1	CARDINAL
admet-1427	87	2	1	CARDINAL
admet-1427	87	3	1	CARDINAL
admet-1427	87	4	2	CARDINAL
admet-1427	88	1	𝑉d 𝑉a	PERSON
admet-1427	88	2	3	CARDINAL
admet-1427	88	3	rv	GPE
admet-1427	90	1	17	CARDINAL
admet-1427	91	1	1	CARDINAL
admet-1427	92	1	0.1	CARDINAL
admet-1427	92	2	enx	ORG
admet-1427	92	3	nflx	ORG
admet-1427	92	4	0.36	CARDINAL
admet-1427	93	1	96	CARDINAL
admet-1427	93	2	one	CARDINAL
admet-1427	94	1	0 to 45 min	TIME
admet-1427	95	1	17	CARDINAL
admet-1427	96	1	one	CARDINAL
admet-1427	96	2	2	CARDINAL
admet-1427	97	1	6–9	CARDINAL
admet-1427	98	1	6.5	CARDINAL
admet-1427	100	1	1.0 mm	QUANTITY
admet-1427	100	2	0.5 ml	QUANTITY
admet-1427	100	3	50 mm	QUANTITY
admet-1427	100	4	octanol	PERSON
admet-1427	100	5	2.5 ml	QUANTITY
admet-1427	100	6	15 ml	QUANTITY
admet-1427	101	1	90 min	QUANTITY
admet-1427	101	2	25 °	QUANTITY
admet-1427	102	1	25 °	QUANTITY
admet-1427	102	2	37 °	QUANTITY
admet-1427	106	1	first	ORDINAL
admet-1427	106	2	2	CARDINAL
admet-1427	108	1	0	CARDINAL
admet-1427	108	2	about 30	CARDINAL
admet-1427	109	1	2	CARDINAL
admet-1427	109	2	mw admet & dmpk	ORG
admet-1427	109	3	2022	CARDINAL
admet-1427	109	4	289	CARDINAL
admet-1427	109	5	293	CARDINAL
admet-1427	112	1	+	CARDINAL
admet-1427	113	1	3	CARDINAL
admet-1427	116	1	10-5 cm	QUANTITY
admet-1427	117	1	3	CARDINAL
admet-1427	118	1	nflx	ORG
admet-1427	118	2	18	CARDINAL
admet-1427	119	1	4	CARDINAL
admet-1427	120	1	4	CARDINAL
admet-1427	121	1	2022	CARDINAL
admet-1427	121	2	289	CARDINAL
admet-1427	121	3	6.5	CARDINAL
admet-1427	121	4	1	CARDINAL
admet-1427	122	1	19	CARDINAL
admet-1427	123	1	11	CARDINAL
admet-1427	124	1	10	CARDINAL
admet-1427	126	1	5	CARDINAL
admet-1427	126	2	sec	ORG
admet-1427	128	1	nflx	ORG
admet-1427	128	2	1.35	CARDINAL
admet-1427	128	3	1.38	CARDINAL
admet-1427	128	4	38 %	PERCENT
admet-1427	128	5	83 %	PERCENT
admet-1427	129	1	20,21	CARDINAL
admet-1427	131	1	nflx	ORG
admet-1427	131	2	about 10	CARDINAL
admet-1427	131	3	20 %	PERCENT
admet-1427	132	1	about 30	CARDINAL
admet-1427	133	1	0	CARDINAL
admet-1427	133	2	2a	CARDINAL
admet-1427	134	1	23	CARDINAL
admet-1427	135	1	2b	CARDINAL
admet-1427	137	1	24,25	CARDINAL
admet-1427	141	1	2c	CARDINAL
admet-1427	143	1	9	CARDINAL
admet-1427	144	1	abraham	PERSON
admet-1427	144	2	26	CARDINAL
admet-1427	146	1	nflx	ORG
admet-1427	146	2	4	CARDINAL
admet-1427	147	1	18	CARDINAL
admet-1427	148	1	nflx	ORG
admet-1427	148	2	0.01	CARDINAL
admet-1427	150	1	mg2+	LOC
admet-1427	152	1	3	CARDINAL
admet-1427	154	1	ca2+	PERSON
admet-1427	154	2	mg2+	DATE
admet-1427	154	3	zn2	GPE
admet-1427	156	1	about 50 %	PERCENT
admet-1427	156	2	15 min	TIME
admet-1427	156	3	1.2	CARDINAL
admet-1427	156	4	6.8	CARDINAL
admet-1427	157	1	27	CARDINAL
admet-1427	159	1	2022	CARDINAL
admet-1427	159	2	289	CARDINAL
admet-1427	159	3	295	CARDINAL
admet-1427	160	1	28	CARDINAL
admet-1427	161	1	wallis et al	PERSON
admet-1427	161	2	nflx	ORG
admet-1427	161	3	18	CARDINAL
admet-1427	162	1	nflx complexed	ORG
admet-1427	162	2	6.5	CARDINAL
admet-1427	162	3	2.2 (	PERCENT
admet-1427	162	4	8.5 %	PERCENT
admet-1427	162	5	3.0	CARDINAL
admet-1427	162	6	35 %	PERCENT
admet-1427	162	7	3.8 (	PERCENT
admet-1427	162	8	81 %	PERCENT
admet-1427	162	9	4.0	CARDINAL
admet-1427	162	10	78 %	PERCENT
admet-1427	162	11	7.0 (	PERCENT
admet-1427	162	12	99 %	PERCENT
admet-1427	162	13	ca2+	GPE
admet-1427	162	14	mg2+	GPE
admet-1427	162	15	zn2+	GPE
admet-1427	162	16	al3+	ORG
admet-1427	163	1	+	CARDINAL
admet-1427	165	1	10	CARDINAL
admet-1427	172	1	1	CARDINAL
admet-1427	172	2	a. stojković	PERSON
admet-1427	172	3	l. tajber	PERSON
admet-1427	172	4	k.j.	GPE
admet-1427	172	5	z. djurić	PERSON
admet-1427	172	6	j. parojčić	PERSON
admet-1427	172	7	o.i. corrigan.	PERSON
admet-1427	175	1	64	CARDINAL
admet-1427	175	2	2014	DATE
admet-1427	175	3	77–88	CARDINAL
admet-1427	177	1	2	CARDINAL
admet-1427	177	2	simon	PERSON
admet-1427	177	3	b. katja	PERSON
admet-1427	177	4	marjan	PERSON
admet-1427	177	5	k. albin	PERSON
admet-1427	179	1	j. pharm	ORG
admet-1427	181	1	53 (2010	DATE
admet-1427	182	1	655–659	DATE
admet-1427	184	1	3	CARDINAL
admet-1427	184	2	martin	PERSON
admet-1427	186	1	j. med	PERSON
admet-1427	187	1	6	CARDINAL
admet-1427	187	2	1963	DATE
admet-1427	187	3	16–20	DATE
admet-1427	189	1	4	CARDINAL
admet-1427	189	2	r. krishna	PERSON
admet-1427	189	3	l. east	GPE
admet-1427	189	4	larson	ORG
admet-1427	189	5	c. valiathan	GPE
admet-1427	189	6	k. butterfield	PERSON
admet-1427	189	7	y. teng	PERSON
admet-1427	189	8	m. hernandez-illas	PERSON
admet-1427	190	1	1200	CARDINAL
admet-1427	191	1	j. pharm	ORG
admet-1427	193	1	68	CARDINAL
admet-1427	193	2	2016	CARDINAL
admet-1427	195	1	5	CARDINAL
admet-1427	195	2	pitman	PERSON
admet-1427	195	3	hoang	PERSON
admet-1427	195	4	c.h	GPE
admet-1427	195	5	wi	ORG
admet-1427	195	6	m. alsheikh	PERSON
admet-1427	195	7	d.a. hiner	PERSON
admet-1427	195	8	percival	PERSON
admet-1427	197	1	8 (2019	CARDINAL
admet-1427	199	1	6	CARDINAL
admet-1427	199	2	m. kansy	PERSON
admet-1427	199	3	f. senner	PERSON
admet-1427	199	4	k. gubernator	PERSON
admet-1427	201	1	j. med. chem	PERSON
admet-1427	201	2	41	CARDINAL
admet-1427	201	3	1998	DATE
admet-1427	201	4	1007-1010	DATE
admet-1427	203	1	7	CARDINAL
admet-1427	203	2	a. avdeef	PERSON
admet-1427	203	3	s. bendels	PERSON
admet-1427	203	4	l. di	PERSON
admet-1427	203	5	m. kansy	PERSON
admet-1427	203	6	k. sugano	PERSON
admet-1427	203	7	y. yamauchi	ORG
admet-1427	205	1	j. pharm	ORG
admet-1427	206	1	sci	ORG
admet-1427	207	1	96	DATE
admet-1427	207	2	2007	DATE
admet-1427	209	1	8	CARDINAL
admet-1427	209	2	l. di	PERSON
admet-1427	209	3	p. artursson	PERSON
admet-1427	209	4	a. avdeef	PERSON
admet-1427	209	5	l.z. benet	PERSON
admet-1427	209	6	j.b.	PERSON
admet-1427	209	7	houston	GPE
admet-1427	209	8	m. kansy	PERSON
admet-1427	209	9	kerns	PERSON
admet-1427	209	10	h. lennernäs	PERSON
admet-1427	209	11	d.a. smith	PERSON
admet-1427	209	12	k. sugano	PERSON
admet-1427	212	1	2020) 1862-1874	DATE
admet-1427	214	1	9	CARDINAL
admet-1427	214	2	k. sugano	PERSON
admet-1427	214	3	m. kansy	PERSON
admet-1427	214	4	p. artursson	PERSON
admet-1427	214	5	a. avdeef	PERSON
admet-1427	214	6	s. bendels	PERSON
admet-1427	214	7	l. di	PERSON
admet-1427	214	8	g.f. ecker	ORG
admet-1427	214	9	b. faller	PERSON
admet-1427	214	10	h. fischer	PERSON
admet-1427	214	11	g. gerebtzoff	PERSON
admet-1427	214	12	h. lennernaes	PERSON
admet-1427	214	13	f. senner	PERSON
admet-1427	216	1	nat	PERSON
admet-1427	218	1	9 (2010	DATE
admet-1427	218	2	597	CARDINAL
admet-1427	219	1	http://dx.doi.org/10.5599/admet.1427 https://doi.org/10.2478/acph-2014-0007 https://doi.org/10.1016/j.jpba.2010.05.021 https://doi.org/10.1021/jm00337a003	DATE
admet-1427	219	2	2022	CARDINAL
admet-1427	219	3	289	CARDINAL
admet-1427	219	4	10	CARDINAL
admet-1427	219	5	s. yamauchi	PERSON
admet-1427	219	6	d. inoue	PERSON
admet-1427	219	7	k. sugano	PERSON
admet-1427	221	1	8	CARDINAL
admet-1427	221	2	2020) 129138	DATE
admet-1427	223	1	11	CARDINAL
admet-1427	223	2	s. yamauchi	PERSON
admet-1427	223	3	k. sugano	PERSON
admet-1427	224	1	7	CARDINAL
admet-1427	224	2	2019) 151–160	DATE
admet-1427	226	1	12	CARDINAL
admet-1427	226	2	f. sörgel	PERSON
admet-1427	226	3	j. bulitta	PERSON
admet-1427	226	4	m. kinzig-schippers	PERSON
admet-1427	228	1	unserer zeit	ORG
admet-1427	229	1	2001	DATE
admet-1427	230	1	418–427	CARDINAL
admet-1427	231	1	https://doi.org/10.1002/1615-1003(200109)30:5<418::aid-pauz418>3.0.co;2%23	CARDINAL
admet-1427	231	2	august 24	DATE
admet-1427	231	3	2022	CARDINAL
admet-1427	232	1	13	CARDINAL
admet-1427	232	2	m. caianelo	PERSON
admet-1427	232	3	c. rodrigues-silva	PERSON
admet-1427	232	4	m.g. maniero	GPE
admet-1427	232	5	j.r. guimarães	PERSON
admet-1427	235	1	sci. pol.	ORG
admet-1427	237	1	24	CARDINAL
admet-1427	237	2	2017) 6288-6298	DATE
admet-1427	239	1	14	CARDINAL
admet-1427	239	2	daiichi sankyo company	ORG
admet-1427	239	3	https://www.info.pmda.go.jp/go/pack/6241013c2024_1_21	CARDINAL
admet-1427	239	4	august 24	DATE
admet-1427	239	5	2022	CARDINAL
admet-1427	240	1	15	CARDINAL
admet-1427	240	2	ch.v.p	ORG
admet-1427	241	1	rao	ORG
admet-1427	241	2	n.a. qureshi	GPE
admet-1427	241	3	h.a. alsubaie	PERSON
admet-1427	241	4	m.k. alharbi	GPE
admet-1427	241	5	ali	PERSON
admet-1427	241	6	s.m.	GPE
admet-1427	241	7	alsanad, s.a. ali	PERSON
admet-1427	241	8	s. mahanand	PERSON
admet-1427	241	9	s.w	GPE
admet-1427	241	10	khan	GPE
admet-1427	241	11	k.t.	GPE
admet-1427	241	12	magalhães-guedes	PERSON
admet-1427	241	13	j.i.	GPE
admet-1427	241	14	druzian	GPE
admet-1427	241	15	r.f. schwan	PERSON
admet-1427	241	16	i.l. nunes	GPE
admet-1427	241	17	costa	GPE
admet-1427	241	18	t. attard	GPE
admet-1427	241	19	e. attard	PERSON
admet-1427	241	20	l.m.	GPE
admet-1427	241	21	shengo	GPE
admet-1427	241	22	t.h. mundongo	PERSON
admet-1427	242	1	i.u.	PERSON
admet-1427	242	2	umoh	GPE
admet-1427	242	3	a.u. ekanem	GPE
admet-1427	242	4	s.u. rehman	GPE
admet-1427	242	5	h.m. rafique	GPE
admet-1427	242	6	qureshi	ORG
admet-1427	242	7	s. shahid	PERSON
admet-1427	243	1	kang	PERSON
admet-1427	244	1	kim	PERSON
admet-1427	245	1	kang	PERSON
admet-1427	245	2	i. dey	PERSON
admet-1427	245	3	t.k. das	PERSON
admet-1427	245	4	c. roy	PERSON
admet-1427	245	5	m.k. pillai	PERSON
admet-1427	245	6	s. magama	PERSON
admet-1427	245	7	l.i. santi	PERSON
admet-1427	245	8	n. katsuto	PERSON
admet-1427	245	9	s. jin-ichi	PERSON
admet-1427	245	10	b. mangla	GPE
admet-1427	245	11	a. jain	PERSON
admet-1427	247	1	1	CARDINAL
admet-1427	247	2	2020	DATE
admet-1427	249	1	16	CARDINAL
admet-1427	249	2	fujifilm toyama chemical co. ltd.	ORG
admet-1427	249	3	august 24	DATE
admet-1427	249	4	2022	CARDINAL
admet-1427	250	1	17	CARDINAL
admet-1427	251	1	second	ORDINAL
admet-1427	251	2	john wiley & sons, inc.	ORG
admet-1427	251	3	2012	DATE
admet-1427	253	1	18	CARDINAL
admet-1427	253	2	s.c. wallis	GPE
admet-1427	253	3	b.g. charles	GPE
admet-1427	253	4	l.r. gahan	PERSON
admet-1427	253	5	l.j.	ORG
admet-1427	253	6	filippich	PERSON
admet-1427	253	7	m.g. bredhauer	GPE
admet-1427	253	8	p.a. duckworth	GPE
admet-1427	256	1	j. pharm	PERSON
admet-1427	257	1	sci	ORG
admet-1427	257	2	85 (1996	DATE
admet-1427	257	3	803–809	DATE
admet-1427	259	1	19	CARDINAL
admet-1427	259	2	a. avdeef	PERSON
admet-1427	259	3	o. tsinman	PERSON
admet-1427	259	4	n. sun	PERSON
admet-1427	261	1	j. med	PERSON
admet-1427	262	1	53	CARDINAL
admet-1427	262	2	2010	DATE
admet-1427	263	1	392–401	CARDINAL
admet-1427	265	1	20	CARDINAL
admet-1427	265	2	n. campbell	PERSON
admet-1427	265	3	m. kara	PERSON
admet-1427	265	4	b. hasinoff	PERSON
admet-1427	265	5	w. haddara	PERSON
admet-1427	265	6	d. mckay	PERSON
admet-1427	266	1	norfloxacin	ORG
admet-1427	268	1	j. clin	PERSON
admet-1427	270	1	33 (1992	DATE
admet-1427	271	1	115–116	CARDINAL
admet-1427	273	1	21	CARDINAL
admet-1427	274	1	bayer	ORG
admet-1427	275	1	https://www.info.pmda.go.jp/go/pack/6241008f1023_1_23/	PERSON
admet-1427	275	2	august 24	DATE
admet-1427	275	3	2022	CARDINAL
admet-1427	276	1	22	CARDINAL
admet-1427	276	2	m. bermejo	PERSON
admet-1427	276	3	a. avdeef	PERSON
admet-1427	276	4	a. ruiz	PERSON
admet-1427	276	5	r. nalda	PERSON
admet-1427	276	6	j.a.	GPE
admet-1427	276	7	ruell	GPE
admet-1427	276	8	o. tsinman	PERSON
admet-1427	276	9	i. gonzález	PERSON
admet-1427	276	10	c. fernández	PERSON
admet-1427	276	11	g. sánchez	PERSON
admet-1427	276	12	garrigues	ORG
admet-1427	277	1	pampa	ORG
admet-1427	277	2	7	CARDINAL
admet-1427	277	3	caco2	ORG
admet-1427	279	1	j. pharm	ORG
admet-1427	280	1	sci	ORG
admet-1427	280	2	21 (2004	DATE
admet-1427	280	3	429–441	CARDINAL
admet-1427	281	1	23	CARDINAL
admet-1427	281	2	p.e	NORP
admet-1427	281	3	a. avdeef	PERSON
admet-1427	282	1	pampa	ORG
admet-1427	282	2	8	CARDINAL
admet-1427	284	1	j. pharm	ORG
admet-1427	285	1	sci	ORG
admet-1427	286	1	22 (2004	DATE
admet-1427	288	1	24	CARDINAL
admet-1427	288	2	xiang	PERSON
admet-1427	288	3	xu	PERSON
admet-1427	288	4	b.d. anderson	PERSON
admet-1427	290	1	j. membr	PERSON
admet-1427	292	1	165	CARDINAL
admet-1427	292	2	1998	DATE
admet-1427	292	3	77	CARDINAL
admet-1427	293	1	https://doi.org/10.1007/s002329900422	ORG
admet-1427	294	1	25	CARDINAL
admet-1427	294	2	j.m.	GPE
admet-1427	294	3	y. katz	PERSON
admet-1427	296	1	j. membr	PERSON
admet-1427	298	1	17 (1974	DATE
admet-1427	298	2	121	CARDINAL
admet-1427	300	1	26	CARDINAL
admet-1427	300	2	abraham	PERSON
admet-1427	304	1	22	CARDINAL
admet-1427	304	2	1993	DATE
admet-1427	304	3	73	CARDINAL
admet-1427	307	1	https://www.info.pmda.go.jp/go/pack/6241013c2024_1_21	CARDINAL
admet-1427	307	2	https://doi.org/10.9734/bpi/tprd/v1	ORG
admet-1427	307	3	https://www.info.pmda.go.jp/go/pack/6241008f1023_1_23/ https://www.info.pmda.go.jp/go/pack/6241008f1023_1_23/	PERSON
admet-1427	307	4	https://doi.org/10.1016/j.ejps.2003.10.009	CARDINAL
admet-1427	308	1	2022	CARDINAL
admet-1427	308	2	289	CARDINAL
admet-1427	308	3	http://dx.doi.org/10.5599/admet.1427 297	DATE
admet-1427	308	4	27	CARDINAL
admet-1427	310	1	august 24	DATE
admet-1427	310	2	2022	CARDINAL
admet-1427	311	1	28	CARDINAL
admet-1427	311	2	b. urbaniak	PERSON
admet-1427	311	3	z.j.	GPE
admet-1427	315	1	647	CARDINAL
admet-1427	315	2	2009	DATE
admet-1427	316	1	https://doi.org/10.1016/j.aca.2009.05.039	GPE
admet-1427	317	1	2022	CARDINAL
admet-1427	317	2	iapc	ORG
admet-1427	317	3	zagreb	GPE
admet-1427	317	4	croatia	GPE
admet-1427	318	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-1427	318	2	https://doi.org/10.1016/j.aca.2009.05.039	GPE